Vimarsana
Biggest News Aggregation in the World

Page 4 - Therapeutics Taskforce News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutics Taskforce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutics Taskforce Today - Breaking & Trending Today

Vitamin C 'helps improve Covid-19 recovery rates' - Vimarsana News

Vitamin C 'helps improve Covid-19 recovery rates'

Vitamin C ‘helps improve Covid-19 recovery rates’ The more you give, the better the results, campaigners say Patrick Holford, VitaminC4Covid.com Vitamin C could drastically reduce the impact Covid-19 is having on people diagnosed with the disease, campaigners claimed today (May 10). Patrick Holford, a nutritionist from global campaign group VitaminC4Covid.com, was commenting after details of a planned anti-Covid treatment similar to Tamiflu (oseltamivir) emerged. The British spent more than £500 million (€580m) developing Tamiflu after swine flu struck in 2009, he said. But citing stud...

Source: imt.ie
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 - Vimarsana News

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Share Early treatment with inhaled budesonide shortens recovery time by a median of three days in patients with COVID-19 who are at higher risk of more severe illness and are treated in the community, finds Oxford University’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial. PRINCIPLE is the world’s largest Phase 3 platform randomised controlled trial to find clear evidence of an effective COVID-19 treatment for use in the community that can significantly shorten recovery time. As one of the UK Government’s national priority platform trials,...

Indian variant still under investigation in UK, not yet of concern: Boris Johnson - Vimarsana News

Indian variant still under investigation in UK, not yet of concern: Boris Johnson

Indian variant still under investigation in UK, not yet of concern: Boris Johnson SECTIONS Last Updated: Apr 21, 2021, 08:43 AM IST Share Synopsis "The Indian variant is still just a variant under investigation, not a variant of concern," he said, adding that experts are currently looking carefully to see if there is any sign the variant B.1.617 can "escape the effect of vaccines". AP UK Prime Minister Boris Johnson was on Tuesday forced to defend what has been widely dubbed a delayed cancellation of his visit to India next week, which has been linked with the addition of India to the travel ...

UK Government launches COVID-19 Antivirals Taskforce to roll out innovative home treatments this autumn - Vimarsana News

UK Government launches COVID-19 Antivirals Taskforce to roll out innovative home treatments this autumn

Share A new Antivirals Taskforce has been launched by the government to identify treatments for UK patients who have been exposed to COVID-19 to stop the infection spreading and speed up recovery time. The taskforce will search for the most promising novel antiviral medicines that can be taken at home and support their development through clinical trials to ensure they can be rapidly rolled out to patients as early as the autumn. The taskforce will also look at opportunities to onshore the manufacture of antiviral treatments. The aim is to have at least 2 effective treatments this year, eithe...

UK government launches search for at-home COVID-19 treatments - Vimarsana News

UK government launches search for at-home COVID-19 treatments

UK government launches search for at-home COVID-19 treatments 21st April 2021 The UK government has launched a new Antivirals Taskforce in a bid to identify promising home treatments for people who have been exposed to COVID-19. The new taskforce will begin the search for novel antiviral medicines that can be taken at home to curb the spread of COVID-19 infection and also speed up recovery time for patients. The taskforce will support treatments through clinical trials to enable the rapid roll-out of any promising medicines to patients as early as Autumn. In addition to identifying novel trea...